CA1039274A - Diagnostic agent - Google Patents

Diagnostic agent

Info

Publication number
CA1039274A
CA1039274A CA228,779A CA228779A CA1039274A CA 1039274 A CA1039274 A CA 1039274A CA 228779 A CA228779 A CA 228779A CA 1039274 A CA1039274 A CA 1039274A
Authority
CA
Canada
Prior art keywords
water
particles
polysaccharide
suspension
cross
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
CA228,779A
Other languages
English (en)
French (fr)
Other versions
CA228779S (en
Inventor
Ulf S. E. Rothman
Bernt J. Lindberg
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Pfizer Health AB
Original Assignee
Pharmacia AB
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pharmacia AB filed Critical Pharmacia AB
Application granted granted Critical
Publication of CA1039274A publication Critical patent/CA1039274A/en
Expired legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
    • A61K51/12—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by a special physical form, e.g. emulsion, microcapsules, liposomes, characterized by a special physical form, e.g. emulsions, dispersions, microcapsules
    • A61K51/1217—Dispersions, suspensions, colloids, emulsions, e.g. perfluorinated emulsion, sols
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/0004—Screening or testing of compounds for diagnosis of disorders, assessment of conditions, e.g. renal clearance, gastric emptying, testing for diabetes, allergy, rheuma, pancreas functions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
    • A61K51/12—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by a special physical form, e.g. emulsion, microcapsules, liposomes, characterized by a special physical form, e.g. emulsions, dispersions, microcapsules
    • A61K51/1241—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by a special physical form, e.g. emulsion, microcapsules, liposomes, characterized by a special physical form, e.g. emulsions, dispersions, microcapsules particles, powders, lyophilizates, adsorbates, e.g. polymers or resins for adsorption or ion-exchange resins
    • A61K51/1244—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by a special physical form, e.g. emulsion, microcapsules, liposomes, characterized by a special physical form, e.g. emulsions, dispersions, microcapsules particles, powders, lyophilizates, adsorbates, e.g. polymers or resins for adsorption or ion-exchange resins microparticles or nanoparticles, e.g. polymeric nanoparticles
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08B—POLYSACCHARIDES; DERIVATIVES THEREOF
    • C08B31/00—Preparation of derivatives of starch
    • C08B31/003—Crosslinking of starch
    • C08B31/006—Crosslinking of derivatives of starch
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2123/00—Preparations for testing in vivo

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Optics & Photonics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Physics & Mathematics (AREA)
  • Dispersion Chemistry (AREA)
  • Endocrinology (AREA)
  • Materials Engineering (AREA)
  • Biomedical Technology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Pathology (AREA)
  • Rheumatology (AREA)
  • Toxicology (AREA)
  • Urology & Nephrology (AREA)
  • Biochemistry (AREA)
  • Diabetes (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Polymers & Plastics (AREA)
  • Organic Chemistry (AREA)
  • Nanotechnology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
CA228,779A 1974-06-06 1975-06-05 Diagnostic agent Expired CA1039274A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE7407461A SE420566B (sv) 1974-06-06 1974-06-06 Diagnostiseringsmedel for intravaskuler administrering

Publications (1)

Publication Number Publication Date
CA1039274A true CA1039274A (en) 1978-09-26

Family

ID=20321348

Family Applications (1)

Application Number Title Priority Date Filing Date
CA228,779A Expired CA1039274A (en) 1974-06-06 1975-06-05 Diagnostic agent

Country Status (8)

Country Link
JP (1) JPS517113A (cg-RX-API-DMAC7.html)
AU (1) AU8164675A (cg-RX-API-DMAC7.html)
CA (1) CA1039274A (cg-RX-API-DMAC7.html)
DE (1) DE2524278A1 (cg-RX-API-DMAC7.html)
FR (1) FR2273516A1 (cg-RX-API-DMAC7.html)
GB (1) GB1518813A (cg-RX-API-DMAC7.html)
NL (1) NL7506743A (cg-RX-API-DMAC7.html)
SE (1) SE420566B (cg-RX-API-DMAC7.html)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0093757A1 (en) * 1981-11-12 1983-11-16 Ulf SCHRÖDER Intravascularly administrable, magnetically responsive nanosphere or nanoparticle, a process for the production thereof, and the use thereof
FR2548902B1 (fr) * 1983-07-13 1986-04-11 Guerbet Sa Gel pour embolisation therapeutique
SE463651B (sv) * 1983-12-21 1991-01-07 Nycomed As Diagnostikum och kontrastmedel

Also Published As

Publication number Publication date
NL7506743A (nl) 1975-12-09
AU8164675A (en) 1976-12-02
GB1518813A (en) 1978-07-26
FR2273516B1 (cg-RX-API-DMAC7.html) 1979-01-05
FR2273516A1 (fr) 1976-01-02
SE7407461L (sv) 1975-12-08
SE420566B (sv) 1981-10-19
JPS517113A (cg-RX-API-DMAC7.html) 1976-01-21
DE2524278A1 (de) 1975-12-18

Similar Documents

Publication Publication Date Title
CA1037950A (en) Agent for intravascular administration
US4126669A (en) Diagnostic agent
Zolle et al. Preparation of metabolizable radioactive human serum albumin microspheres for studies of the circulation
Cortesi et al. Sugar cross-linked gelatin for controlled release: microspheres and disks
JPH08501286A (ja) 変性ポリマーマイクロカプセルによる診断および治療方法
EP4112085A1 (en) Visualized radioactive carbon microsphere, and preparation method and application thereof
US20060014938A1 (en) Stable aqueous colloidal lanthanide oxides
AU2008278976B2 (en) Polysaccharides grafted by polyamines for the preparation of radiopharmaceutical compositions
EP0730871B1 (en) Radioactive chitosan complex and the use thereof for radiation therapy
WO2022041802A1 (zh) 一种锆炭微球混悬液及其制备方法和用途
Dhua et al. Carboxylated gums as additives in the production of interpenetrating hydrogel beads and slow release of glimepiride
CN104258420B (zh) 一种具有肝癌靶向功能的低代数树状大分子包裹的金纳米颗粒作为ct纳米造影剂的制备方法
EP0989137B1 (en) Diagnostic agents for pancreatic exocrine function
Anitha et al. Evaluation of the in vivo fate of ultrapure alginate in a BALB/c mouse model
CN115814110A (zh) 功能化聚乙烯亚胺纳米复合材料的制备及其诊疗应用
Onishi et al. Characterization and evaluation of dialdehyde starch as an erodible medical polymer and a drug carrier
Selek et al. Formulation and in vitro/in vivo evaluation of terbutaline sulphate incorporated in PLGA (25/75) and L-PLA microspheres
Yang et al. Dual-radiolabelling of an injectable hyaluronan-tyramine-bisphosphonate hybrid gel for in vitro and in vivo tracking
Padmasri et al. Preparation and evaluation of adipic dihydrazide cross-linked hyaluronic acid microspheres for cephalexin
LI et al. RADIOPHARMAZEUTISCHE ZUSAMMENSETZUNGEN DIE POLYAMINE GEPFROPFTE POLYSACCHARIDE ENTHALTEN COMPOSITIONS RADIOPHARMACEUTIQUES COMPRENANT DES POLYSACCHARIDES GREFFÉS AVEC DES POLYAMINES
HK1149211B (en) Polysaccharides grafted by polyamines for the preparation of radiopharmaceutical compositions
DE2524278A1 (de) Diagnostisches mittel, hilfsmittel zu dessen herstellung sowie diagnoseverfahren
Gundogdu et al. " Tc-sodium pertechnetate was obtained